GlassScriptPhysician profile
Ramon N Torres
NPI 1184621807
$4,951.68
in general payments reported to CMS, 2019-2025
34 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $360 · 2021: $818 · 2022: $1,064 · 2023: $873 · 2024: $805 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $725.27 | 2021-2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $501.17 | 2022-2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $363.21 | 2019-2024 | |
| Cvrx, INC. | $337.14 | 2021-2025 | Barostim Neo System |
| Amgen INC. | $317.01 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $293.61 | 2019-2025 | Wainua, Farxiga |
| Janssen Pharmaceuticals, INC | $289.32 | 2019-2022 | |
| Pfizer INC. | $281.57 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.79 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $231.52 | 2022-2023 | |
| Philips North America LLC | $221.74 | 2022-2025 | (Ck7) Extended Holter, Holter, Extended Holter |
| Boston Scientific Corporation | $188.91 | 2019-2023 | Watchman Access System |
| Cook Medical LLC | $140.83 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.68 | 2019-2025 | Lifevest |
| Abbott Laboratories | $99.51 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $74.18 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $57.46 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $54.91 | 2023-2024 | Inpefa |
| Medtronic Vascular, INC. | $49.43 | 2019-2020 | |
| Abiomed | $46.54 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $42.94 | 2019 | |
| Kestra Medical Technology Services, INC. | $33.42 | 2023 | Assure Wcd |
| Braemar Manufacturing, LLC | $32.97 | 2019 | |
| Irhythm Technologies, INC. | $30.84 | 2022-2023 | Zio Xt Patch |
| Atricure, INC. | $21.60 | 2022 | |
| Esperion Therapeutics, INC. | $21.32 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.97 | 2022 | |
| Portola Pharmaceuticals, LLC | $15.72 | 2019 | |
| Astellas Pharma US INC | $15.20 | 2019 | |
| Vital Connect, INC | $14.65 | 2024 | Vitalpatch Rtm |
| Biotronik INC. | $14.02 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.98 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.